nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—CA4—Alzheimer's disease	0.806	1	CbGaD
Methyclothiazide—CA2—Erythrocytes take up carbon dioxide and release oxygen—CA4—Alzheimer's disease	0.00978	0.172	CbGpPWpGaD
Methyclothiazide—CA1—Erythrocytes take up carbon dioxide and release oxygen—CA4—Alzheimer's disease	0.00937	0.165	CbGpPWpGaD
Methyclothiazide—CA2—Reversible hydration of carbon dioxide—CA4—Alzheimer's disease	0.00777	0.137	CbGpPWpGaD
Methyclothiazide—CA1—Reversible hydration of carbon dioxide—CA4—Alzheimer's disease	0.00745	0.131	CbGpPWpGaD
Methyclothiazide—Glycosuria—Donepezil—Alzheimer's disease	0.00265	0.0244	CcSEcCtD
Methyclothiazide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC24A4—Alzheimer's disease	0.00232	0.041	CbGpPWpGaD
Methyclothiazide—Vascular purpura—Galantamine—Alzheimer's disease	0.00225	0.0207	CcSEcCtD
Methyclothiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC24A4—Alzheimer's disease	0.00211	0.0372	CbGpPWpGaD
Methyclothiazide—Hyperuricaemia—Memantine—Alzheimer's disease	0.0021	0.0194	CcSEcCtD
Methyclothiazide—SLC12A1—forebrain—Alzheimer's disease	0.0021	0.0991	CbGeAlD
Methyclothiazide—Purpura—Galantamine—Alzheimer's disease	0.00209	0.0192	CcSEcCtD
Methyclothiazide—Blood uric acid increased—Memantine—Alzheimer's disease	0.00199	0.0183	CcSEcCtD
Methyclothiazide—Vasculitis—Rivastigmine—Alzheimer's disease	0.00196	0.018	CcSEcCtD
Methyclothiazide—SLC12A1—telencephalon—Alzheimer's disease	0.00193	0.0911	CbGeAlD
Methyclothiazide—Orthostatic hypotension—Galantamine—Alzheimer's disease	0.00184	0.0169	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Memantine—Alzheimer's disease	0.00174	0.016	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Donepezil—Alzheimer's disease	0.00173	0.0159	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.0017	0.0156	CcSEcCtD
Methyclothiazide—Vascular purpura—Memantine—Alzheimer's disease	0.00158	0.0146	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Galantamine—Alzheimer's disease	0.00157	0.0144	CcSEcCtD
Methyclothiazide—Pneumonia—Galantamine—Alzheimer's disease	0.00156	0.0144	CcSEcCtD
Methyclothiazide—Vascular purpura—Rivastigmine—Alzheimer's disease	0.00155	0.0143	CcSEcCtD
Methyclothiazide—Purpura—Memantine—Alzheimer's disease	0.00147	0.0135	CcSEcCtD
Methyclothiazide—CA1—forebrain—Alzheimer's disease	0.00145	0.0682	CbGeAlD
Methyclothiazide—Purpura—Rivastigmine—Alzheimer's disease	0.00144	0.0132	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.00143	0.0131	CcSEcCtD
Methyclothiazide—Cramp muscle—Donepezil—Alzheimer's disease	0.00141	0.0129	CcSEcCtD
Methyclothiazide—CA1—telencephalon—Alzheimer's disease	0.00133	0.0627	CbGeAlD
Methyclothiazide—Pancreatitis—Donepezil—Alzheimer's disease	0.00132	0.0122	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Memantine—Alzheimer's disease	0.00129	0.0119	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.00127	0.0116	CcSEcCtD
Methyclothiazide—Cramp muscle—Rivastigmine—Alzheimer's disease	0.00125	0.0115	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00122	0.0112	CcSEcCtD
Methyclothiazide—Malnutrition—Galantamine—Alzheimer's disease	0.00121	0.0112	CcSEcCtD
Methyclothiazide—Pneumonia—Donepezil—Alzheimer's disease	0.00121	0.0111	CcSEcCtD
Methyclothiazide—Pancreatitis—Memantine—Alzheimer's disease	0.0012	0.011	CcSEcCtD
Methyclothiazide—Pancreatitis—Rivastigmine—Alzheimer's disease	0.00117	0.0108	CcSEcCtD
Methyclothiazide—Jaundice—Donepezil—Alzheimer's disease	0.00117	0.0108	CcSEcCtD
Methyclothiazide—Muscle spasms—Galantamine—Alzheimer's disease	0.00117	0.0107	CcSEcCtD
Methyclothiazide—Metolazone—CA4—Alzheimer's disease	0.00114	0.148	CrCbGaD
Methyclothiazide—Vision blurred—Galantamine—Alzheimer's disease	0.00114	0.0105	CcSEcCtD
Methyclothiazide—SLC12A1—nervous system—Alzheimer's disease	0.00114	0.0538	CbGeAlD
Methyclothiazide—CA4—forebrain—Alzheimer's disease	0.00113	0.0533	CbGeAlD
Methyclothiazide—Agitation—Galantamine—Alzheimer's disease	0.00111	0.0103	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Memantine—Alzheimer's disease	0.0011	0.0102	CcSEcCtD
Methyclothiazide—SLC12A1—central nervous system—Alzheimer's disease	0.0011	0.0518	CbGeAlD
Methyclothiazide—Pneumonia—Memantine—Alzheimer's disease	0.0011	0.0101	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00109	0.0101	CcSEcCtD
Methyclothiazide—Vertigo—Galantamine—Alzheimer's disease	0.00109	0.01	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00108	0.00996	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.00108	0.00994	CcSEcCtD
Methyclothiazide—Pneumonia—Rivastigmine—Alzheimer's disease	0.00107	0.00988	CcSEcCtD
Methyclothiazide—CA2—embryo—Alzheimer's disease	0.00106	0.05	CbGeAlD
Methyclothiazide—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.00106	0.00974	CcSEcCtD
Methyclothiazide—CA4—telencephalon—Alzheimer's disease	0.00104	0.049	CbGeAlD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC24A4—Alzheimer's disease	0.00104	0.0183	CbGpPWpGaD
Methyclothiazide—Cyclothiazide—CA4—Alzheimer's disease	0.00104	0.134	CrCbGaD
Methyclothiazide—Benzthiazide—CA4—Alzheimer's disease	0.00104	0.134	CrCbGaD
Methyclothiazide—Diclofenamide—CA4—Alzheimer's disease	0.00103	0.133	CrCbGaD
Methyclothiazide—Chlorothiazide—CA4—Alzheimer's disease	0.00103	0.133	CrCbGaD
Methyclothiazide—Agranulocytosis—Memantine—Alzheimer's disease	0.00102	0.00937	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000969	0.00891	CcSEcCtD
Methyclothiazide—Anorexia—Galantamine—Alzheimer's disease	0.000943	0.00868	CcSEcCtD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC24A4—Alzheimer's disease	0.000943	0.0166	CbGpPWpGaD
Methyclothiazide—Malnutrition—Donepezil—Alzheimer's disease	0.00094	0.00865	CcSEcCtD
Methyclothiazide—CA2—forebrain—Alzheimer's disease	0.000938	0.0442	CbGeAlD
Methyclothiazide—Erythema multiforme—Memantine—Alzheimer's disease	0.000927	0.00853	CcSEcCtD
Methyclothiazide—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000907	0.00834	CcSEcCtD
Methyclothiazide—Muscle spasms—Donepezil—Alzheimer's disease	0.000903	0.00831	CcSEcCtD
Methyclothiazide—Paraesthesia—Galantamine—Alzheimer's disease	0.000889	0.00817	CcSEcCtD
Methyclothiazide—Vision blurred—Donepezil—Alzheimer's disease	0.000886	0.00815	CcSEcCtD
Methyclothiazide—SLC12A1—brain—Alzheimer's disease	0.000872	0.0411	CbGeAlD
Methyclothiazide—Hydroflumethiazide—CA4—Alzheimer's disease	0.000867	0.112	CrCbGaD
Methyclothiazide—Agitation—Donepezil—Alzheimer's disease	0.000864	0.00794	CcSEcCtD
Methyclothiazide—CA2—telencephalon—Alzheimer's disease	0.000862	0.0406	CbGeAlD
Methyclothiazide—Decreased appetite—Galantamine—Alzheimer's disease	0.00086	0.00791	CcSEcCtD
Methyclothiazide—Malnutrition—Memantine—Alzheimer's disease	0.000853	0.00785	CcSEcCtD
Methyclothiazide—Constipation—Galantamine—Alzheimer's disease	0.000846	0.00779	CcSEcCtD
Methyclothiazide—Vertigo—Donepezil—Alzheimer's disease	0.000844	0.00777	CcSEcCtD
Methyclothiazide—Hydrochlorothiazide—CA4—Alzheimer's disease	0.000844	0.109	CrCbGaD
Methyclothiazide—Malnutrition—Rivastigmine—Alzheimer's disease	0.000835	0.00768	CcSEcCtD
Methyclothiazide—Vision blurred—Memantine—Alzheimer's disease	0.000804	0.0074	CcSEcCtD
Methyclothiazide—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000802	0.00738	CcSEcCtD
Methyclothiazide—Vision blurred—Rivastigmine—Alzheimer's disease	0.000787	0.00724	CcSEcCtD
Methyclothiazide—CA1—nervous system—Alzheimer's disease	0.000785	0.037	CbGeAlD
Methyclothiazide—Agitation—Memantine—Alzheimer's disease	0.000784	0.00721	CcSEcCtD
Methyclothiazide—Body temperature increased—Galantamine—Alzheimer's disease	0.000782	0.0072	CcSEcCtD
Methyclothiazide—Agitation—Rivastigmine—Alzheimer's disease	0.000767	0.00706	CcSEcCtD
Methyclothiazide—Vertigo—Memantine—Alzheimer's disease	0.000767	0.00705	CcSEcCtD
Methyclothiazide—Leukopenia—Memantine—Alzheimer's disease	0.000764	0.00703	CcSEcCtD
Methyclothiazide—CA1—central nervous system—Alzheimer's disease	0.000756	0.0356	CbGeAlD
Methyclothiazide—Trichlormethiazide—CA4—Alzheimer's disease	0.000752	0.0973	CrCbGaD
Methyclothiazide—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000751	0.00691	CcSEcCtD
Methyclothiazide—Vertigo—Rivastigmine—Alzheimer's disease	0.00075	0.0069	CcSEcCtD
Methyclothiazide—Anorexia—Donepezil—Alzheimer's disease	0.000731	0.00673	CcSEcCtD
Methyclothiazide—Hypersensitivity—Galantamine—Alzheimer's disease	0.000729	0.00671	CcSEcCtD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC30A6—Alzheimer's disease	0.00072	0.0127	CbGpPWpGaD
Methyclothiazide—Asthenia—Galantamine—Alzheimer's disease	0.00071	0.00653	CcSEcCtD
Methyclothiazide—Paraesthesia—Donepezil—Alzheimer's disease	0.000689	0.00634	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Memantine—Alzheimer's disease	0.000682	0.00627	CcSEcCtD
Methyclothiazide—Diarrhoea—Galantamine—Alzheimer's disease	0.000677	0.00623	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000667	0.00614	CcSEcCtD
Methyclothiazide—Decreased appetite—Donepezil—Alzheimer's disease	0.000667	0.00613	CcSEcCtD
Methyclothiazide—Anorexia—Memantine—Alzheimer's disease	0.000664	0.00611	CcSEcCtD
Methyclothiazide—Constipation—Donepezil—Alzheimer's disease	0.000656	0.00603	CcSEcCtD
Methyclothiazide—Dizziness—Galantamine—Alzheimer's disease	0.000654	0.00602	CcSEcCtD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC30A6—Alzheimer's disease	0.000654	0.0115	CbGpPWpGaD
Methyclothiazide—Anorexia—Rivastigmine—Alzheimer's disease	0.000649	0.00597	CcSEcCtD
Methyclothiazide—Vomiting—Galantamine—Alzheimer's disease	0.000629	0.00579	CcSEcCtD
Methyclothiazide—Paraesthesia—Memantine—Alzheimer's disease	0.000625	0.00575	CcSEcCtD
Methyclothiazide—Rash—Galantamine—Alzheimer's disease	0.000624	0.00574	CcSEcCtD
Methyclothiazide—Dermatitis—Galantamine—Alzheimer's disease	0.000623	0.00573	CcSEcCtD
Methyclothiazide—Headache—Galantamine—Alzheimer's disease	0.00062	0.0057	CcSEcCtD
Methyclothiazide—CA4—nervous system—Alzheimer's disease	0.000614	0.0289	CbGeAlD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—APOD—Alzheimer's disease	0.000612	0.0108	CbGpPWpGaD
Methyclothiazide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000612	0.00563	CcSEcCtD
Methyclothiazide—Urticaria—Donepezil—Alzheimer's disease	0.000609	0.00561	CcSEcCtD
Methyclothiazide—Body temperature increased—Donepezil—Alzheimer's disease	0.000606	0.00558	CcSEcCtD
Methyclothiazide—Decreased appetite—Memantine—Alzheimer's disease	0.000605	0.00557	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—MPO—Alzheimer's disease	0.000605	0.0107	CbGpPWpGaD
Methyclothiazide—CA1—brain—Alzheimer's disease	0.0006	0.0283	CbGeAlD
Methyclothiazide—Constipation—Memantine—Alzheimer's disease	0.000595	0.00548	CcSEcCtD
Methyclothiazide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000592	0.00545	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000592	0.0104	CbGpPWpGaD
Methyclothiazide—CA4—central nervous system—Alzheimer's disease	0.000591	0.0279	CbGeAlD
Methyclothiazide—Nausea—Galantamine—Alzheimer's disease	0.000588	0.00541	CcSEcCtD
Methyclothiazide—Constipation—Rivastigmine—Alzheimer's disease	0.000583	0.00536	CcSEcCtD
Methyclothiazide—CA4—cerebellum—Alzheimer's disease	0.000578	0.0272	CbGeAlD
Methyclothiazide—Hypersensitivity—Donepezil—Alzheimer's disease	0.000565	0.0052	CcSEcCtD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—APOD—Alzheimer's disease	0.000556	0.0098	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—PPP3CA—Alzheimer's disease	0.000554	0.00977	CbGpPWpGaD
Methyclothiazide—Urticaria—Memantine—Alzheimer's disease	0.000553	0.00509	CcSEcCtD
Methyclothiazide—Body temperature increased—Memantine—Alzheimer's disease	0.00055	0.00506	CcSEcCtD
Methyclothiazide—Asthenia—Donepezil—Alzheimer's disease	0.00055	0.00506	CcSEcCtD
Methyclothiazide—Urticaria—Rivastigmine—Alzheimer's disease	0.000541	0.00498	CcSEcCtD
Methyclothiazide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000539	0.00495	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000538	0.00948	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000528	0.0093	CbGpPWpGaD
Methyclothiazide—Diarrhoea—Donepezil—Alzheimer's disease	0.000525	0.00483	CcSEcCtD
Methyclothiazide—Hypersensitivity—Memantine—Alzheimer's disease	0.000513	0.00472	CcSEcCtD
Methyclothiazide—CA2—nervous system—Alzheimer's disease	0.000509	0.024	CbGeAlD
Methyclothiazide—Dizziness—Donepezil—Alzheimer's disease	0.000507	0.00467	CcSEcCtD
Methyclothiazide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000502	0.00462	CcSEcCtD
Methyclothiazide—Asthenia—Memantine—Alzheimer's disease	0.0005	0.0046	CcSEcCtD
Methyclothiazide—CA2—central nervous system—Alzheimer's disease	0.00049	0.0231	CbGeAlD
Methyclothiazide—Asthenia—Rivastigmine—Alzheimer's disease	0.000489	0.0045	CcSEcCtD
Methyclothiazide—Vomiting—Donepezil—Alzheimer's disease	0.000488	0.00449	CcSEcCtD
Methyclothiazide—Rash—Donepezil—Alzheimer's disease	0.000484	0.00445	CcSEcCtD
Methyclothiazide—Dermatitis—Donepezil—Alzheimer's disease	0.000483	0.00444	CcSEcCtD
Methyclothiazide—Headache—Donepezil—Alzheimer's disease	0.00048	0.00442	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000479	0.00845	CbGpPWpGaD
Methyclothiazide—CA2—cerebellum—Alzheimer's disease	0.000479	0.0226	CbGeAlD
Methyclothiazide—Diarrhoea—Memantine—Alzheimer's disease	0.000476	0.00438	CcSEcCtD
Methyclothiazide—CA4—brain—Alzheimer's disease	0.000469	0.0221	CbGeAlD
Methyclothiazide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000466	0.00429	CcSEcCtD
Methyclothiazide—Dizziness—Memantine—Alzheimer's disease	0.00046	0.00424	CcSEcCtD
Methyclothiazide—Nausea—Donepezil—Alzheimer's disease	0.000456	0.00419	CcSEcCtD
Methyclothiazide—Dizziness—Rivastigmine—Alzheimer's disease	0.00045	0.00414	CcSEcCtD
Methyclothiazide—Vomiting—Memantine—Alzheimer's disease	0.000443	0.00407	CcSEcCtD
Methyclothiazide—Rash—Memantine—Alzheimer's disease	0.000439	0.00404	CcSEcCtD
Methyclothiazide—Dermatitis—Memantine—Alzheimer's disease	0.000439	0.00404	CcSEcCtD
Methyclothiazide—Headache—Memantine—Alzheimer's disease	0.000436	0.00401	CcSEcCtD
Methyclothiazide—Vomiting—Rivastigmine—Alzheimer's disease	0.000433	0.00398	CcSEcCtD
Methyclothiazide—Rash—Rivastigmine—Alzheimer's disease	0.00043	0.00395	CcSEcCtD
Methyclothiazide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000429	0.00395	CcSEcCtD
Methyclothiazide—Headache—Rivastigmine—Alzheimer's disease	0.000427	0.00393	CcSEcCtD
Methyclothiazide—Nausea—Memantine—Alzheimer's disease	0.000414	0.00381	CcSEcCtD
Methyclothiazide—Nausea—Rivastigmine—Alzheimer's disease	0.000405	0.00372	CcSEcCtD
Methyclothiazide—CA2—brain—Alzheimer's disease	0.000389	0.0183	CbGeAlD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.000384	0.00678	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000366	0.00645	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.000349	0.00615	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000332	0.00586	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000311	0.00548	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000282	0.00498	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—BCL2—Alzheimer's disease	0.000225	0.00396	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—PTGS2—Alzheimer's disease	0.000213	0.00376	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000195	0.00344	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—DHCR24—Alzheimer's disease	0.000194	0.00341	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—DHCR24—Alzheimer's disease	0.000186	0.00327	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—DHCR24—Alzheimer's disease	0.000178	0.00314	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000177	0.00313	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000166	0.00293	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CA4—Alzheimer's disease	0.000158	0.00278	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GAPDHS—Alzheimer's disease	0.000155	0.00273	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CA4—Alzheimer's disease	0.000151	0.00267	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000151	0.00266	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GAPDHS—Alzheimer's disease	0.000148	0.00262	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ATP5A1—Alzheimer's disease	0.000147	0.00259	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GAPDHS—Alzheimer's disease	0.000142	0.00251	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ATP5A1—Alzheimer's disease	0.000141	0.00248	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PLD3—Alzheimer's disease	0.00014	0.00247	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ATP5A1—Alzheimer's disease	0.000135	0.00238	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PLD3—Alzheimer's disease	0.000134	0.00237	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—HSD17B10—Alzheimer's disease	0.000134	0.00237	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP46A1—Alzheimer's disease	0.000129	0.00228	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HSD17B10—Alzheimer's disease	0.000129	0.00227	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PLD3—Alzheimer's disease	0.000129	0.00227	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ND1—Alzheimer's disease	0.000125	0.0022	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP46A1—Alzheimer's disease	0.000124	0.00218	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—HSD17B10—Alzheimer's disease	0.000123	0.00217	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ND1—Alzheimer's disease	0.00012	0.00211	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP46A1—Alzheimer's disease	0.000119	0.00209	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000116	0.00205	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ND1—Alzheimer's disease	0.000115	0.00202	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000105	0.00186	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CHAT—Alzheimer's disease	8.04e-05	0.00142	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—TPI1—Alzheimer's disease	8.04e-05	0.00142	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—TPI1—Alzheimer's disease	7.71e-05	0.00136	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CHAT—Alzheimer's disease	7.71e-05	0.00136	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—MAOB—Alzheimer's disease	7.71e-05	0.00136	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GAPDH—Alzheimer's disease	7.42e-05	0.00131	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—MAOB—Alzheimer's disease	7.39e-05	0.0013	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—TPI1—Alzheimer's disease	7.39e-05	0.0013	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CHAT—Alzheimer's disease	7.39e-05	0.0013	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—A2M—Alzheimer's disease	7.17e-05	0.00126	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GAPDH—Alzheimer's disease	7.11e-05	0.00125	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—MAOB—Alzheimer's disease	7.09e-05	0.00125	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—A2M—Alzheimer's disease	6.87e-05	0.00121	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GAPDH—Alzheimer's disease	6.82e-05	0.0012	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—A2M—Alzheimer's disease	6.59e-05	0.00116	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ACHE—Alzheimer's disease	6.23e-05	0.0011	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—INPP5D—Alzheimer's disease	6.16e-05	0.00109	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ACHE—Alzheimer's disease	5.98e-05	0.00105	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—INPP5D—Alzheimer's disease	5.91e-05	0.00104	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ENO1—Alzheimer's disease	5.84e-05	0.00103	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PTGS1—Alzheimer's disease	5.84e-05	0.00103	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ACHE—Alzheimer's disease	5.73e-05	0.00101	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP2D6—Alzheimer's disease	5.73e-05	0.00101	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—INPP5D—Alzheimer's disease	5.66e-05	0.000999	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ENO1—Alzheimer's disease	5.6e-05	0.000987	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PTGS1—Alzheimer's disease	5.6e-05	0.000987	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP2D6—Alzheimer's disease	5.49e-05	0.000968	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—BCHE—Alzheimer's disease	5.43e-05	0.000957	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PTGS1—Alzheimer's disease	5.37e-05	0.000947	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ENO1—Alzheimer's disease	5.37e-05	0.000947	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP2D6—Alzheimer's disease	5.27e-05	0.000928	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—BCHE—Alzheimer's disease	5.21e-05	0.000918	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PLCB1—Alzheimer's disease	5.12e-05	0.000903	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—BCHE—Alzheimer's disease	4.99e-05	0.00088	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ABCA1—Alzheimer's disease	4.97e-05	0.000876	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PLCB1—Alzheimer's disease	4.91e-05	0.000866	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ABCA1—Alzheimer's disease	4.76e-05	0.00084	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PLCB1—Alzheimer's disease	4.71e-05	0.00083	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ABCA1—Alzheimer's disease	4.57e-05	0.000805	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PPARGC1A—Alzheimer's disease	4.28e-05	0.000755	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—HMOX1—Alzheimer's disease	4.26e-05	0.000751	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PPARGC1A—Alzheimer's disease	4.1e-05	0.000724	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HMOX1—Alzheimer's disease	4.09e-05	0.00072	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PPARGC1A—Alzheimer's disease	3.94e-05	0.000694	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—HMOX1—Alzheimer's disease	3.92e-05	0.000691	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—LPL—Alzheimer's disease	3.9e-05	0.000687	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—LPL—Alzheimer's disease	3.74e-05	0.000659	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—LPL—Alzheimer's disease	3.58e-05	0.000632	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—MTHFR—Alzheimer's disease	3.51e-05	0.000619	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—MTHFR—Alzheimer's disease	3.36e-05	0.000593	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CALM1—Alzheimer's disease	3.28e-05	0.000578	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—APOE—Alzheimer's disease	3.27e-05	0.000576	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CAV1—Alzheimer's disease	3.24e-05	0.000571	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—MTHFR—Alzheimer's disease	3.23e-05	0.000569	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CALM1—Alzheimer's disease	3.14e-05	0.000554	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—APOE—Alzheimer's disease	3.13e-05	0.000552	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CAV1—Alzheimer's disease	3.1e-05	0.000547	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CALM1—Alzheimer's disease	3.01e-05	0.000531	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—APOE—Alzheimer's disease	3e-05	0.000529	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CAV1—Alzheimer's disease	2.98e-05	0.000525	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PPARG—Alzheimer's disease	2.85e-05	0.000502	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—INS—Alzheimer's disease	2.79e-05	0.000492	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PPARG—Alzheimer's disease	2.73e-05	0.000481	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—INS—Alzheimer's disease	2.68e-05	0.000472	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PPARG—Alzheimer's disease	2.62e-05	0.000461	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—INS—Alzheimer's disease	2.57e-05	0.000452	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NOS3—Alzheimer's disease	2.45e-05	0.000432	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NOS3—Alzheimer's disease	2.35e-05	0.000414	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NOS3—Alzheimer's disease	2.25e-05	0.000397	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PTGS2—Alzheimer's disease	2.24e-05	0.000395	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PTGS2—Alzheimer's disease	2.15e-05	0.000378	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PTGS2—Alzheimer's disease	2.06e-05	0.000363	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—AKT1—Alzheimer's disease	1.13e-05	0.000198	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—AKT1—Alzheimer's disease	1.08e-05	0.00019	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—AKT1—Alzheimer's disease	1.03e-05	0.000182	CbGpPWpGaD
